Cargando…

First Account of Psychological Changes Perceived by a Female with Congenital Leptin Deficiency upon Treatment with Metreleptin

Two psychiatric interviews of a 39-year old female with congenital leptin deficiency were conducted to define psychological changes 14 and 165 days after initiation of treatment with human recombinant leptin (metreleptin). The most pronounced initial experience related to the reduced preoccupation w...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hebebrand, Johannes, Zorn, Stefanie, Antel, Jochen, von Schnurbein, Julia, Wabitsch, Martin, Gradl-Dietsch, Gertraud
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	S. Karger AG 2022
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9669943/ https://www.ncbi.nlm.nih.gov/pubmed/35952649 http://dx.doi.org/10.1159/000526169

Ejemplares similares

Case report: Rapid improvements of anorexia nervosa and probable myalgic encephalomyelitis/chronic fatigue syndrome upon metreleptin treatment during two dosing episodes
por: Hebebrand, Johannes, et al.
Publicado: (2023)

Rapid Emergence of Appetite and Hunger Resulting in Weight Gain and Improvement of Eating Disorder Symptomatology during and after Short-Term Off-Label Metreleptin Treatment of a Patient with Anorexia Nervosa
por: Gradl-Dietsch, Gertraud, et al.
Publicado: (2022)

Suggestive Evidence for an Antidepressant Effect of Metreleptin Treatment in Patients with Lipodystrophy
por: Vieira, Diana Branco, et al.
Publicado: (2022)

Need for psychiatric phenotyping in patients with rare genetic disorders
por: Degenhardt, Franziska, et al.
Publicado: (2021)

The Metreleptin Effectiveness and Safety Registry (MEASuRE): concept, design and challenges
por: Haymond, Morey W, et al.
Publicado: (2023)

Short-term metreleptin treatment of patients with anorexia nervosa: rapid on-set of beneficial cognitive, emotional, and behavioral effects
por: Milos, Gabriella, et al.
Publicado: (2020)

Diagnostic and therapeutic odyssey of two patients with compound heterozygous leptin receptor deficiency
por: Zorn, Stefanie, et al.
Publicado: (2020)

Perceived impact of the COVID-19 pandemic on child and adolescent psychiatric services after 1 year (February/March 2021): ESCAP CovCAP survey
por: Revet, Alexis, et al.
Publicado: (2021)

Rapid amelioration of anorexia nervosa in a male adolescent during metreleptin treatment including recovery from hypogonadotropic hypogonadism
por: Antel, Jochen, et al.
Publicado: (2021)

Serum IGF1 and linear growth in children with congenital leptin deficiency before and after leptin substitution
por: Beghini, Marianna, et al.
Publicado: (2021)

Clinical Trials Required to Assess Potential Benefits and Side Effects of Treatment of Patients With Anorexia Nervosa With Recombinant Human Leptin
por: Hebebrand, Johannes, et al.
Publicado: (2019)

Efficacy of Metreleptin in Obese Patients With Type 2 Diabetes: Cellular and Molecular Pathways Underlying Leptin Tolerance
por: Moon, Hyun-Seuk, et al.
Publicado: (2011)

Lower Circulating Leptin Levels Are Related to Non-Alcoholic Fatty Liver Disease in Children With Obesity
por: Brandt, Stephanie, et al.
Publicado: (2022)

Long-Term Stabilization Effects of Leptin on Brain Functions in a Leptin-Deficient Patient
por: Frank, Sabine, et al.
Publicado: (2013)

A fresh look to the phenotype in mono-allelic likely pathogenic variants of the leptin and the leptin receptor gene
por: Koerber-Rosso, Ingrid, et al.
Publicado: (2021)

Metreleptin therapy in LMNA-linked lipodystrophies
por: Vatier, Camille, et al.
Publicado: (2015)

Metreleptin and Metformin Use in an Infant With Congenital Generalized Lipodystrophy Secondary to AGPAT2 Mutation
por: Schweisberger, Cintya, et al.
Publicado: (2021)

OR33-02 The Treatment of Partial Lipodystrophy in the Setting of Neutralizing Antibody Against Metreleptin with Leptin Receptor Agonist REGN4461
por: Akinci, Baris, et al.
Publicado: (2020)

Monogenic forms of childhood obesity due to mutations in the leptin gene
por: Funcke, Jan-Bernd, et al.
Publicado: (2014)

Metreleptin treatment for congenital generalized lipodystrophy type 4 (CGL4): a case report
por: Takeyari, Shinji, et al.
Publicado: (2019)

Metreleptin Treatment in Three Patients with Generalized Lipodystrophy
por: Musso, Carla, et al.
Publicado: (2017)

Measurement of immunofunctional leptin to detect and monitor patients with functional leptin deficiency
por: Wabitsch, Martin, et al.
Publicado: (2016)

Prevalence estimates of putatively pathogenic leptin variants in the gnomAD database
por: Rajcsanyi, Luisa Sophie, et al.
Publicado: (2022)

Functional and Phenotypic Characteristics of Human Leptin Receptor Mutations
por: Nunziata, Adriana, et al.
Publicado: (2018)

New advances in the treatment of generalized lipodystrophy: role of metreleptin
por: Rodriguez, Alexander J, et al.
Publicado: (2015)

Experience with an OSCE anamnesis station via Zoom: Feasibility, acceptance and challenges from the perspective of students, simulated patients and examiners during the COVID-19 pandemic
por: Herbstreit, Stephanie, et al.
Publicado: (2022)

Metreleptin Robustly Increases Resting-state Brain Connectivity in Treatment-naïve Female Patients With Lipodystrophy
por: Schlögl, Haiko, et al.
Publicado: (2023)

Adherence with metreleptin therapy and health self-perception in patients with lipodystrophic syndromes
por: Vatier, Camille, et al.
Publicado: (2019)

Risk factors for diabetic foot ulcers in metreleptin naïve patients with lipodystrophy
por: Saydam, O, et al.
Publicado: (2021)

SUN-607 Iron Parameters in Patients with Partial Lipodystrophy and Impact of Metreleptin Therapy
por: Boutros, Sabine, et al.
Publicado: (2020)

Suggestive Evidence for Causal Effect of Leptin Levels on Risk for Anorexia Nervosa: Results of a Mendelian Randomization Study
por: Peters, Triinu, et al.
Publicado: (2021)

Severe Early-Onset Obesity Due to Bioinactive Leptin Caused by a p.N103K Mutation in the Leptin Gene
por: Wabitsch, Martin, et al.
Publicado: (2015)

Peyton’s four-step approach for teaching complex spinal manipulation techniques – a prospective randomized trial
por: Gradl-Dietsch, Gertraud, et al.
Publicado: (2016)

Efficacy and Safety of Metreleptin in Patients with Partial Lipodystrophy: Lessons from an Expanded Access Program
por: Ajluni, Nevin, et al.
Publicado: (2016)

Diagnosis of acquired generalized lipodystrophy in a single patient with T-cell lymphoma and no exposure to Metreleptin
por: Esfandiari, Nazanene H., et al.
Publicado: (2019)

OR17-02 Changes in Hepatokines and Apolipoproteins Are Associated with Metabolic Response to Metreleptin in Partial Lipodystrophy
por: Akinci, Baris, et al.
Publicado: (2020)

FRI056 Effect Of 48 Hour Of Metreleptin In Humans With Lipodystrophy During Controlled Feeding
por: Bukhari, Khulood M, et al.
Publicado: (2023)

SAT676 Severe Recurrent Pancreatitis In A Familial Partial Lipodystrophy Patient On Metreleptin
por: Sargin, Pinar, et al.
Publicado: (2023)

Acquired partial lipoatrophy as graft-versus-host disease and treatment with metreleptin: two case reports
por: Shibata, Yusuke, et al.
Publicado: (2018)

Metreleptin Supplementation for Improving Lipid and Glycemic Profiles in Acquired Diabetes Lipodystrophy: A Case Report
por: Nagayama, Ayako, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_bhbukc68fss4go6llhtg9aoo0o